Below are a series of case studies highlighting how the MolecuLight i:X integrates in wound care protocols and guides clinicians in their wound care practice.
 Interim data from 27 patients in ongoing Post Market Clinical Follow-up Study (Positive Predictive Value of the MolecuLight i:X Imaging Device to Predict the Presence of Bacteria in Chronic Wounds; MLI Study 16-101).
 Interim data from 16 patients in ongoing clinical trial (Positive Predictive Value of the MolecuLight i:X Imaging Device to Predict the Presence of Bacteria in Chronic Wounds; clinicaltrials.gov registry number NCT02682069).
 DaCosta RS, Kulbatski I, Lindvere-Teene L, Starr D, Blackmore K, Silver JI, Opoku J, Wu YC, Medeiros PJ, Xu W, et al. Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PLoS One. 2015 Mar 19;10(3).
 Ottolino-Perry K, Chamma E, Blackmore K, Lindvere-Teene L, Starr D, Tapang K, Rosen C, Pitcher B, Panzarella T, Linden R, DaCosta RS. Improved detection of wound bacteria using fluorescence image-guided wound sampling in diabetic foot ulcers. Int Wound J. 2016 (In revisions).
 Landis S. Wound Mapping: A Guide to Targeted Debridement and Wound Healing. [accessed 2016 Dec 7]. http://moleculight.com/wound-mapping-guide-targeted-debridement-wound-healing-webcast/.
 Landis S. Mapping venous ulcers using bacterial autofluorescence to identify subgroups at risk of infection post debridement. Proceedings of the Annual Canadian Association of Wound Care Conference; 2016 Nov 3-6; Niagara Falls, ON.
 Landis S. Determining the effectiveness of sharp debridement using wound/periwound bacterial autofluorescence imaging. Proceedings of the Annual Symposium on Advanced Wound Care; 2016 April 13-17; Atlanta GA.
 Raizman R. Point-of-care bacterial fluorescence imaging device guides care and patient education in obese patients with surgical site infections. Proceedings of the Annual Canadian Association of Wound Care Conference; 2016 Nov 3-6; Niagara Falls, ON.
 MolecuLight. Improved cleaning with MolecuLight i:X led to successful patient outcome [Case study PN 1255]. 2016.
 Blumenthal E, Jeffrey S. The use of MolecuLight i:X in burn wounds. Proceedings of the Annual Australian & New Zealand Burn Association Conference; 2016 Oct 11-14; Auckland NZ.
 MolecuLight. Avoid unnecessary use of antimicrobial dressings with the MolecuLight i:X [Case study 0038]. 2016.
 MolecuLight. Track Wound Size and Bacterial Presence with the MolecuLight i:X [Case study 0051]. 2016.
 Improve Measurement Accuracy of Irregular Wound Borders with the MolecuLight i:X™[Case study 0018].
 The MolecuLight i:X Imaging Device is approved by Health Canada (Medical License #95784)
 Raizman R and DaCosta RS. Handheld real-time fluorescence imaging of bacteria guides treatment selection and timing of dressing changes in inpatients undergoing negative pressure wound therapy. Proceedings of the Innovations in Wound Healing Conference; 2016 Dec 8-11, Key Largo, FL.